Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | APAF1 | O14727 | 1/20 | 0.34 |
| ▸ | NSD2 | O96028 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9621309 | 0.70 | NPC1 (0.43) | KDM4EAPAF1NSD2ALDH1A1TP53 | |
| SCHEMBL2406021 | 0.67 | ACHE (0.53) | KDM4EAPAF1NSD2ALDH1A1TP53 | |
| SCHEMBL9014933 | 0.65 | NPC1 (0.34) | KDM4EAPAF1NSD2ALDH1A1TP53 | |
| SCHEMBL9621167 | 0.65 | MEN1 (0.38) | KDM4EAPAF1NSD2ALDH1A1TP53 | |
| SCHEMBL14572401 | 0.65 | ACHE (0.55) | KDM4EAPAF1NSD2ALDH1A1TP53 | |
| SCHEMBL20303200 | 0.63 | PRNP (0.51) | KDM4EALDH1A1MAPTTDP1L3MBTL1 | |
| SCHEMBL13197744 | 0.62 | KDM4E (0.46) | KDM4EAPAF1NSD2ALDH1A1TP53 | |
| SCHEMBL14380308 | 0.62 | KDM4E (0.46) | KDM4EAPAF1NSD2ALDH1A1TP53 | |
| SCHEMBL6419092 | 0.61 | KDM4E (0.59) | KDM4EAPAF1NSD2ALDH1A1TP53 | |
| SCHEMBL9014728 | 0.59 | NPC1 (0.37) | KDM4EAPAF1NSD2ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105051927-B | Azabenzimidazole carbene ligands as efficiency enhancers in OLEDs | UDC 爱尔兰有限责任公司 | 2020-10-16 | — | — | CN | disclosed |
| US-20190355917-A1 | Organic Electroluminescent Element And Novel Iridium Complex | UDC IRELAND LTD (IE) | 2019-11-21 | — | — | US | disclosed |
| US-20190355917-A1 | Organic Electroluminescent Element And Novel Iridium Complex | UDC IRELAND LTD (IE) | 2019-11-21 | — | — | US | disclosed |
| US-10374172-B2 | Azabenzimidazole carbene complexes as efficiency booster in OLEDs | UDC IRELAND LIMITED (IE) | 2019-08-06 | — | — | US | disclosed |
| US-10374172-B2 | Azabenzimidazole carbene complexes as efficiency booster in OLEDs | UDC IRELAND LIMITED (IE) | 2019-08-06 | — | — | US | disclosed |
| EP-2976793-B1 | USE OF AZABENZIMIDAZOLE CARBENE COMPLEXES IN OLEDS | UDC IRELAND LTD (IE) | 2019-04-24 | — | — | EP | disclosed |
| EP-2976793-B1 | USE OF AZABENZIMIDAZOLE CARBENE COMPLEXES IN OLEDS | UDC IRELAND LTD (IE) | 2019-04-24 | — | — | EP | disclosed |
| US-20160293862-A1 | AZABENZIMIDAZOLE CARBENE COMPLEXES AS EFFICIENCY BOOSTER IN OLEDS | BASF SE (DE) | 2016-10-06 | — | — | US | disclosed |
| US-20160293862-A1 | AZABENZIMIDAZOLE CARBENE COMPLEXES AS EFFICIENCY BOOSTER IN OLEDS | BASF SE (DE) | 2016-10-06 | — | — | US | disclosed |
| US-20160293862-A1 | AZABENZIMIDAZOLE CARBENE COMPLEXES AS EFFICIENCY BOOSTER IN OLEDS | BASF SE (DE) | 2016-10-06 | — | — | US | disclosed |
| EP-2976793-A1 | AZABENZIMIDAZOLE CARBENE COMPLEXES AS EFFICIENCY BOOSTER IN OLEDS | BASF SE (DE) | 2016-01-27 | — | — | EP | disclosed |
| WO-2014147134-A1 | AZABENZIMIDAZOLE CARBENE COMPLEXES AS EFFICIENCY BOOSTER IN OLEDS | BASF SE (DE) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014147134-A1 | AZABENZIMIDAZOLE CARBENE COMPLEXES AS EFFICIENCY BOOSTER IN OLEDS | BASF SE (DE) | 2014-09-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10374172-B2 | Azabenzimidazole carbene complexes as efficiency booster in OLEDs | ICOS, OCIAD2, OXER1 | KDM4E 3189/4885APAF1 4234/4885NSD2 1026/4885 |
| US-20190355917-A1 | Organic Electroluminescent Element And Novel Iridium Complex | INCENP, TRPM6, L1CAM | KDM4E 2304/4885APAF1 3878/4885NSD2 3732/4885 |
| US-20160293862-A1 | AZABENZIMIDAZOLE CARBENE COMPLEXES AS EFFICIENCY BOOSTER IN OLEDS | ICOS, OCIAD2, OXER1 | KDM4E 3189/4885APAF1 4234/4885NSD2 1026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.